Warning! The directory is not yet complete and will be amended until the beginning of the term.
301407 VO DNA-Tumor Viruses, from Cancer Agent to therapy (2021W)
Elective Course in Molecular Medicine
Labels
REMOTE
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Details
Language: English
Examination dates
- Wednesday 15.12.2021 16:00 - 17:00 Digital
- Thursday 17.03.2022 16:00 - 17:00 Digital
- Wednesday 01.06.2022
Lecturers
Classes (iCal) - next class is marked with N
lecture dates: always 2-4pm
November 9th, 11th, 16th, 18th, 23rd, 25th, and 30th
January 25th 2022
March 29th 2022
May 3rd 2022
June 14th 2022
- Thursday 11.11. 14:00 - 16:00 Digital
- Tuesday 16.11. 14:00 - 16:00 Digital
- Thursday 18.11. 14:00 - 16:00 Digital
- Tuesday 23.11. 14:00 - 16:00 Digital
- Thursday 25.11. 14:00 - 16:00 Digital
- Tuesday 30.11. 14:00 - 16:00 Digital
Information
Aims, contents and method of the course
Assessment and permitted materials
Written exam
Minimum requirements and assessment criteria
Maximum points: 40. Usually 4 questions, 10 points/question
Grading key: <20= 5 (insufficient); 20-24 = 4 (sufficient); 25-29 = 3 (satisfactory); 30-34 = 2 (good); 35-40 = 1 (very good)
Grading key: <20= 5 (insufficient); 20-24 = 4 (sufficient); 25-29 = 3 (satisfactory); 30-34 = 2 (good); 35-40 = 1 (very good)
Examination topics
Content of the course. Lectures in English, exam in English. Questions can also be answered in German
Reading list
Course documents in Moodle. Information on the literature available on the slides in Moodle.
Association in the course directory
MMB IV-2, MMB IV-3, MMB W-2, MMEI III, UF MA BU 01, UF MA BU 04
Last modified: Fr 12.05.2023 00:24
The lecture will include the following topics:
Classification of DNA tumour viruses
Lytic and transformation cycle
Viral oncoproteins and their cellular targets: p53, pRB (the retinoblastoma gene product), protein phosphatase 2A (PP2A) and others
Human Papillomavirus and the development of cervical carcinoma
Cancer therapy with adenovirus mutants